凡试用HyCyte®预筛选胎牛血清试用装科研用户,1个月内提交血清试用反馈并上传实验图片与实验数据可获赠海星生物公仔一个。
|
HyCyte®预筛选胎牛血清FBP-C520 影响因子为18.9
Li X, Liang X, Fu W, et al. Reversing cancer immunoediting phases with a tumor-activated and optically reinforced immunoscaffold[J]. Bioactive Materials, 2024, 35: 228-241.
HyCyte®预筛选胎牛血清 影响因子为 5.7
Liu P, Wang Y, Li X, et al. Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer‐associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p‐ACLY axis[J]. Cancer Science, 2024.
HyCyte®干细胞预筛选胎牛血清FBP-S001 影响因子为37.3
Zheng Z, Zeng X, Zhu Y, et al. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis[J]. Molecular Cancer, 2024, 23(1): 4.
HyCyte®预筛选胎牛血清 影响因子 3.4
Zhao X, Zheng Z, Chen C, et al. New clerodane diterpenoids from Callicarpa pseudorubella and their antitumor proliferative activity[J]. Fitoterapia, 2024, 174: 105878.